Gurgaon-based Lanco Infratech Ltd said it won a contract, worth Rs91.66 crore, from Airports Authority of India (AAI) for construction of a new terminal building at Biju Patnaik Airport in Bhubaneswar.
On Friday, Lanco Infratech shares ended 1.2% down at Rs63 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.6% up at 17,117 points.
Welspun Corp Ltd, the flagship company of the Welspun Group, said it won few orders worth Rs700 crore for pipes and plates.
With the addition of these orders, the current order book of the company stands at Rs7,100 crore without excluding the orders being executed in the current quarter.
On Friday, Welspun shares closed 5.3% up at Rs230 on the Bombay Stock Exchange, while the benchmark Sensex ended 0.6% up at 17,117 points.
Lupin Ltd said its US subsidiary Lupin Pharmaceuticals has received US Food and Drug Administration (USFDA) approval for its lamotrigine in tablets form.
Lamotrigine tablets, used in the treatment of bipolar-I disorder, are a generic version of GlaxoSmithKline's branded drug Lamictal, the company said in a statement. The tablets have annual sales of about $452 million in the US market.
Like many other anticonvulsant medications, Lamotrigine also seems to acts as an effective mood stabiliser, and in fact has been the only FDA approved drug for this purpose since lithium, a drug approved almost 30 years earlier.
On Friday, Lupin shares ended 0.1% up at Rs1,849 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.6% up at 17,117 points.